P3 Health Partners (PIII) Common Equity (2019 - 2025)

P3 Health Partners has reported Common Equity for 7 years, with the latest figure at -$155.2 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 304.38% year-over-year to -$155.2 million; the trailing twelve-month figure through Dec 2025 stood at -$155.2 million (down 304.38% YoY), and the FY2025 full-year result was -$155.2 million, down 304.38% from the prior year.
• Common Equity for Q4 2025 stood at -$155.2 million, down from -$18.7 million in the prior quarter.
• The five-year high for Common Equity was $263.0 million in Q1 2022, with the low at -$272.9 million in Q4 2021.
• Historically, Common Equity has averaged $13.2 million across 5 years, with a median of $53.9 million in 2025.
• Annual changes were most pronounced in 2024 — Common Equity surged 5559.81% — and 2025, when it slumped 304.38%.
• P3 Health Partners' Common Equity stood at -$272.9 million in 2021, then surged by 102.14% to $5.9 million in 2022, then jumped by 2327.91% to $142.1 million in 2023, then sank by 46.57% to $75.9 million in 2024, then sank by 304.38% to -$155.2 million in 2025.
• The last three Common Equity figures came in at -$155.2 million (Q4 2025), -$18.7 million (Q3 2025), and $44.5 million (Q2 2025), per Business Quant data.